Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/5096
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEkiz, Hüseyin Atakan-
dc.contributor.authorBaran, Yusuf-
dc.date.accessioned2017-03-20T08:32:13Z-
dc.date.available2017-03-20T08:32:13Z-
dc.date.issued2011-05-
dc.identifier.citationEkiz, H. A., and Baran, Y. (2011). Bioactive Sphingolipids in response to chemotherapy: A scope on Leukemias. Anti-Cancer Agents in Medicinal Chemistry, 11(4), 385-397. doi:10.2174/187152011795677571en_US
dc.identifier.issn1871-5206-
dc.identifier.issn1875-5992-
dc.identifier.urihttp://doi.org/10.2174/187152011795677571-
dc.identifier.urihttp://hdl.handle.net/11147/5096-
dc.description.abstractSphingolipids are major constituents of the cells with emerging roles in the regulation of cellular processes. Deregulation of sphingolipid metabolism is reflected as various pathophysiological conditions including metabolic disorders and several forms of cancer. Ceramides, ceramide-1-phosphate (C1P), glucosyl ceramide (GluCer), sphingosine and sphingosine-1-phosphate (S1P) are among the bioactive sphingolipid species that have important roles in the regulation of cell death, survival and chemotherapeutic resistance. Some of those species are known to accumulate in the cells upon chemotherapy while some others are known to exhibit an opposite pattern. Even though the length of fatty acid chain has a deterministic effect, in general, upregulation of ceramides and sphingosine is known to induce apoptosis. However, S1P, C1P and GluCer are proliferative for cells and they are involved in the development of chemoresistance. Therefore, sphingolipid metabolism appears as a good target for the development of novel therapeutics or supportive interventions to increase the effectiveness of the chemotherapeutic drugs currently in hand. Some approaches involve manipulation of the synthesis pathways yielding the increased production of apoptotic sphingolipids while the proliferative ones are suppressed. Some others are trying to take advantage of cytotoxic sphingolipids like short chain ceramide analogs by directly delivering them to the malignant cells as a distinct chemotherapeutic intervention. Numerous studies in the literature show the feasibility of those approaches especially in acute and chronic leukemias. This review compiles the current knowledge about sphingolipids and their roles in chemotherapeutic response with the particular attention to leukemias. © 2011 Bentham Science Publishers Ltd.en_US
dc.description.sponsorshipTurkish Academy of Sciences Outstanding Young Investigator Programen_US
dc.language.isoenen_US
dc.publisherBentham Science Publishers B.V.en_US
dc.relation.ispartofAnti-Cancer Agents in Medicinal Chemistryen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCeramidesen_US
dc.subjectChemotherapeutic responseen_US
dc.subjectDihydroceramideen_US
dc.subjectGlucosylceramide synthaseen_US
dc.subjectLeukemiaen_US
dc.subjectSphingosine kinaseen_US
dc.titleBioactive sphingolipids in response to chemotherapy: A scope on Leukemiasen_US
dc.typeBook Reviewen_US
dc.authoridTR119193en_US
dc.departmentIzmir Institute of Technology. Molecular Biology and Geneticsen_US
dc.identifier.volume11en_US
dc.identifier.issue4en_US
dc.identifier.startpage385en_US
dc.identifier.endpage397en_US
dc.identifier.wosWOS:000290614400008
dc.identifier.scopusSCOPUS:2-s2.0-79958126314
dc.relation.publicationcategoryDiğeren_US
dc.identifier.doi10.2174/187152011795677571-
dc.relation.doi10.2174/187152011795677571en_US
dc.coverage.doi10.2174/187152011795677571en_US
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeBook Review-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.grantfulltextopen-
crisitem.author.deptDepartment of Molecular Biology and Genetics-
Appears in Collections:Molecular Biology and Genetics / Moleküler Biyoloji ve Genetik
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Files in This Item:
File Description SizeFormat 
5096.pdfİnceleme (Review)431.22 kBAdobe PDFThumbnail
View/Open
Show simple item record

CORE Recommender

SCOPUSTM   
Citations

5
checked on Oct 23, 2021

Page view(s)

48
checked on Oct 23, 2021

Download(s)

32
checked on Oct 23, 2021

Google ScholarTM

Check

Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.